| Protein synthesis inhibition and GADD34 control IFN‐β heterogeneous expression in response to dsRNA A Dalet, RJ Argüello, A Combes, L Spinelli, S Jaeger, M Fallet, TPV Manh, ... The EMBO journal 36 (6), 761-782, 2017 | 75 | 2017 |
| Guanabenz inhibits TLR9 signaling through a pathway that is independent of eIF2α dephosphorylation by the GADD34/PP1c complex J Perego, A Mendes, C Bourbon, V Camosseto, A Combes, H Liu, ... Sci. Signal. 11 (514), eaam8104, 2018 | 20 | 2018 |
| Guanabenz prevents d-galactosamine/lipopolysaccharide-induced liver damage and mortality J Perego, C Bourbon, L Chasson, C Laprie, L Spinelli, V Camosseto, ... Frontiers in immunology 8, 679, 2017 | 19 | 2017 |
| Neurogenesis and viral infections AO Ihunwo, J Perego, G Martino, E Vicenzi, P Panina-Bordignon Frontiers in Immunology, 349, 0 | 10 | |
| Use of guanabenz or derivates thereof for the treatment of type i ifn-dependent pathologies J Perego, P Pierre, E Gatti US Patent App. 17/053,817, 2021 | | 2021 |
| Modulation pharmacologique des voies de signalisation des TLRs par le Guanabenz, un inhibiteur de la réponse au stress J Perego Aix-Marseille, 2016 | | 2016 |
